Nr4a1 siRNA expression attenuates α-MSH regulated gene expression in 3T3-L1 adipocytes.
Several recent investigations have underscored the growing role of melanocortin signaling in the peripheral regulation of lipid, glucose, and energy homeostasis. In addition, the melanocortins play a critical role in the central control of satiety. These observations, and the latest reports highlighting the emerging role of the nuclear hormone receptor (NR) 4A subgroup in metabolism, have prompted us to investigate the cross talk between [Nle(4), d-Phe(7)] (NDP)-α-MSH and Nr4a signaling in adipose. We have shown that NDP-MSH strikingly and preferentially induces the expression of the NR4A subgroup (but not any other members of the NR superfamily) in differentiated 3T3-L1 adipocytes. Utilization of quantitative PCR on custom-designed metabolic TaqMan low-density arrays identified the concomitant and marked induction of the mRNAs encoding Il-6, Cox2, Pdk4, and Pck-1 after NDP-MSH treatment. Similar experiments demonstrated that the mRNA expression profile induced by cAMP and NDP-MSH treatment displayed unique but also overlapping properties and suggested that melanocortin-mediated induction of gene expression involves cAMP-dependent and -independent signaling. Nr4a1/Nur77 small interfering RNA (siRNA) expression suppressed NDP-MSH-mediated induction of Nr4a1/Nur77 and Nr4a3/Nor-1 (but not Nr4a2/Nurr1). Moreover, expression of the siRNA-attenuated NDP-MSH mediated induction of the mRNAs encoding Il-6, Cox2/Ptgs2, and Pck-1 expression. In addition, Nur77 siRNA expression attenuated NDP-MSH-mediated glucose uptake. In vivo, ip administration of NDP-MSH to C57 BL/6J (male) mice significantly induced the expression of the mRNA encoding Nur77 and increased IL-6, Cox2, Pck1, and Pdk4 mRNA expression in (inguinal) adipose tissue. We conclude that Nur77 expression is necessary for MSH-mediated induction of gene expression in differentiated adipocytes. Furthermore, this study demonstrates cross talk between MSH and Nr4a signaling in adipocytes.
Obesity Research Centre, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia.
S-C Mary
SC
Wang
Stephen A
SA
Myers
Natalie A
NA
Eriksson
Rebecca L
RL
Fitzsimmons
George E O
GE
Muscat
D041721:3T3-L1 Cells; D017667:Adipocytes / Q000378:metabolism*; D000818:Animals; D000242:Cyclic AMP / Q000235:genetics / Q000378:metabolism; D051546:Cyclooxygenase 2 / Q000235:genetics / Q000378:metabolism; D015870:Gene Expression; D020869:Gene Expression Profiling; D005947:Glucose / Q000378:metabolism; D015850:Interleukin-6 / Q000235:genetics; D053486:Melanocortins / Q000235:genetics / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D057105:Nuclear Receptor Subfamily 4, Group A, Member 1 / Q000235:genetics* / Q000378:metabolism*; D010729:Phosphoenolpyruvate Carboxykinase (GTP) / Q000235:genetics; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D034741:RNA, Small Interfering / Q000235:genetics*; D015398:Signal Transduction; D000521:alpha-MSH / Q000378:metabolism*
D015850:Interleukin-6; D053486:Melanocortins; C539818:Nr4a1 protein, mouse; D057105:Nuclear Receptor Subfamily 4, Group A, Member 1; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D000521:alpha-MSH; D000242:Cyclic AMP; D051546:Cyclooxygenase 2; D010729:Phosphoenolpyruvate Carboxykinase (GTP); D005947:Glucose
J Mol Endocrinol. 2010 Apr;44(4):225-36
20089716
Peptides. 2005 Oct;26(10):1788-99
16046247
Mol Endocrinol. 2001 May;15(5):783-96
11328858
Nat Neurosci. 2005 May;8(5):571-8
15856065
Diabetes. 2002 May;51(5):1337-45
11978628
Trends Cardiovasc Med. 2007 Apr;17(3):105-11
17418373
Mol Endocrinol. 2005 Oct;19(10):2466-77
16051664
Nat Med. 1999 Sep;5(9):1066-70
10470087
Cold Spring Harb Symp Quant Biol. 2007;72:387-94
18419296
Stat Appl Genet Mol Biol. 2004;3:Article3
16646809
Peptides. 2010 Jan;31(1):116-22
19799952
Int J Obes (Lond). 2009 May;33(5):519-24
19238156
J Biol Chem. 2008 May 2;283(18):12564-70
18292087
Trends Endocrinol Metab. 2004 Apr;15(3):129-35
15046742
Peptides. 2009 Jun;30(6):1098-104
19463742
J Cell Biochem. 2005 Nov 1;96(4):869-78
16155875
Eur J Biochem. 1995 Dec 1;234(2):390-6
8536680
Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E121-31
17374695
J Clin Invest. 2001 Oct;108(7):1079-85
11581309
Nucl Recept Signal. 2006;4:e002
16604165
Mol Cell Endocrinol. 2003 Feb 28;200(1-2):99-109
12644303
Methods Mol Biol. 2008;456:307-15
18516571
J Clin Invest. 2001 Jun;107(12):1491-5
11413152
Diabetes. 2009 Dec;58(12):2788-96
19741162
J Biol Chem. 2005 Apr 1;280(13):12573-84
15640143
J Biol Chem. 2007 Oct 26;282(43):31525-33
17785466
Diabetes. 2006 Oct;55(10):2688-97
17003332
Nat Med. 2006 Sep;12(9):1048-55
16906154
Mol Endocrinol. 2005 Oct;19(10):2437-50
16051663
Biochem Biophys Res Commun. 1996 Mar 18;220(2):241-5
8645290
Mol Cell Biol. 1995 Jan;15(1):351-7
7799943
Obes Res. 2005 Apr;13(4):653-61
15897473
J Biochem. 2007 Feb;141(2):181-92
17167038
J Endocrinol. 2007 Apr;193(1):1-9
17400797
Mol Cell Endocrinol. 2009 Oct 15;309(1-2):101-8
19465082
Histol Histopathol. 2006 May;21(5):533-40
16493583
Diabetes. 2006 Feb;55(2):273-80
16443757
Curr Opin Lipidol. 2007 Oct;18(5):515-20
17885421
Mol Endocrinol. 2007 Sep;21(9):2152-63
17550977
Diabetes. 2008 Sep;57(9):2272-9
18519799
Prog Mol Biol Transl Sci. 2009;88:85-153
20374726
Cell. 2006 Aug 25;126(4):801-10
16923398
Peptides. 2005 Oct;26(10):1818-24
15992961
Mol Endocrinol. 2008 May;22(5):1057-64
18238829
Ann N Y Acad Sci. 1999 Oct 20;885:75-84
10816642
Endocrinology. 2008 Jun;149(6):2853-65
18325999
Endocrinology. 2006 Nov;147(11):5217-27
16901967
J Med Chem. 1997 May 23;40(11):1738-48
9171884
Prostaglandins Other Lipid Mediat. 2001 Jul;65(4):199-209
11444591
J Clin Invest. 2007 Nov;117(11):3475-88
17885689
Diabetes. 2009 May;58(5):1086-95
19188427